Tag: Weight Loss
Weight Reduction Varies for Patients Receiving Semaglutide, Liraglutide
Weight reduction at one year linked to medication active agent, dosage, treatment indication, persistence of coverage
At Least One in Five People Has Obesity in Each U.S. State
CDC data show that in 23 states, 35 percent or more of the population is now obese
Weight-Loss Drug Zepbound Now in Single-Dose Vials at Half the Price
Only One-Quarter of Patients Still Taking Semaglutide for Weight Loss Two Years Later
Nonadherence likely owed to mix of side effects such as nausea and vomiting and out-of-pocket costs
Significantly More Weight Loss Seen With Tirzepatide Versus Semaglutide
Patients with overweight, obesity receiving tirzepatide significantly more likely to achieve ≥5, ≥10, and ≥15 percent weight loss
WHO, Lilly Issue Warnings About Fake Weight-Loss Drugs
Meal Replacement + Financial Incentives Beneficial for Teens With Obesity
For teens with severe obesity, meal replacement therapy plus financial incentives result in greater reduction in BMI, fat mass
Insulin-Treated T2D Patients Unwilling to Participate in Intensive Lifestyle Intervention
Adults with insulin-treated T2D unwilling to participate in lifestyle intervention mainly because intervention is too intense
Weight Navigation Program Boosts Use of Weight Management Treatments
Greater use of weight management treatments seen with WNP, including bariatric surgery, low-calorie meal replacement
Semaglutide Has Lasting Benefit for Weight Loss
Second study shows cardiovascular benefit for semaglutide, regardless of weight loss
